Sirolimus

FYARRO, HYFTOR

mTOR Inhibitor Immunosuppressant

NADAC/unit $1.3262

No Shortage Tier 1: 79.0% PA Req: 407.0% 10 Manufacturers 17 ANDAs

vs. brand FYARRO: Generic saves up to 87% per unit

Covered Lives

Market Intelligence

2024-05-29 Class III Recall: Dr. Reddy's Laboratories, Inc.

Generic Manufacturers

AADI SUBSIDIARY INCALKEM LABORATORIES LTDAMNEAL PHARMACEUTICALS LLCAPOTEX INCDR REDDYS LABORATORIES LTDGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT VMSN LABORATORIES PRIVATE LTDNOBELPHARMA CO LTDNOVITIUM PHARMA LLCPF PRISM CVRISING PHARMA HOLDINGS INCZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Sirolimus drfinder.aiFind doctors who prescribe Sirolimus rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Sirolimus

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.